Literature DB >> 15361180

Histopathologic parameters of prognosis in cervical cancer--a review.

N Singh1, S Arif.   

Abstract

Apart from clinical stage and lymph node status, acknowledged to be among the most powerful predictors of outcome in cervical cancer, the determination of prognosis and thereby the need for adjuvant therapy in surgically treated patients currently relies on a variety of histopathologic factors. The role of many of these is controversial. This may be because histopathology is genuinely lacking in sensitivity for predicting tumor behavior in vivo. There is, however, wide variation in histopathologic definitions and criteria. This is probably the major reason for both the lack of reproducibility in the reporting of certain factors and in their diminished value in predicting behavior. Tumor type, grade, vascular invasion, pattern of invasion, and depth are all extremely important prognostic indicators when used individually or as a part of a scoring system.

Entities:  

Mesh:

Year:  2004        PMID: 15361180     DOI: 10.1111/j.1048-891X.2004.014504.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  26 in total

Review 1.  [The 2019 FIGO classification for cervical carcinoma-what's new?]

Authors:  L-C Horn; C E Brambs; S Opitz; U A Ulrich; A K Höhn
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

2.  Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials.

Authors:  Bradley J Monk; Chunqiao Tian; Peter G Rose; Rachelle Lanciano
Journal:  Gynecol Oncol       Date:  2007-02-02       Impact factor: 5.482

3.  [S3 guidelines on diagnostics and treatment of cervical cancer: Demands on pathology].

Authors:  L-C Horn; M W Beckmann; M Follmann; M C Koch; P Mallmann; S Marnitz; D Schmidt
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

4.  Primary tumor SUVmax on preoperative FDG-PET/CT is a prognostic indicator in stage IA2-IIB cervical cancer patients treated with radical hysterectomy.

Authors:  Shigetaka Yagi; Tamaki Yahata; Yasushi Mabuchi; Yuko Tanizaki; Aya Kobayashi; Michihisa Shiro; Nami Ota; Sawako Minami; Masaki Terada; Kazuhiko Ino
Journal:  Mol Clin Oncol       Date:  2016-07-07

5.  Prediction of local recurrence in cervical cancer by a Cox model comprised of lymph node status, lymph-vascular space invasion, and intratumoral Th17 cell-infiltration.

Authors:  Qing Yu; Xiang-Ming Lou; Yan He
Journal:  Med Oncol       Date:  2013-12-06       Impact factor: 3.064

6.  [Cervical cancer : Update on morphology].

Authors:  L-C Horn; C E Brambs; R Handzel; S Lax; I Sändig; D Schmidt; K Schierle
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

7.  Perineural invasion in early-stage cervical cancer and its relevance following surgery.

Authors:  Yi Zhu; Guonan Zhang; Yan Yang; Ling Cui; Shijun Jia; Yu Shi; Shuiqin Song; Shiqiang Xu
Journal:  Oncol Lett       Date:  2018-02-26       Impact factor: 2.967

Review 8.  [Grading of gynecological tumors : Current aspects].

Authors:  L-C Horn; D Mayr; C E Brambs; J Einenkel; I Sändig; K Schierle
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

Review 9.  Invasive stratified mucin-producing carcinoma (i-SMILE) of the uterine cervix: report of a case series and review of the literature indicating poor prognostic subtype of cervical adenocarcinoma.

Authors:  Lars-Christian Horn; Romy Handzel; Gudrun Borte; Udo Siebolts; Anja Haak; Christine E Brambs
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-05       Impact factor: 4.553

10.  Neoangiogenesis in early cervical cancer: correlation between color Doppler findings and risk factors. A prospective observational study.

Authors:  Matias Jurado; Rosendo Galván; Rafael Martinez-Monge; Jesús Mazaira; Juan Luis Alcazar
Journal:  World J Surg Oncol       Date:  2008-11-25       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.